Therapeutic efficacy of α-radioimmunotherapy with different activity levels of the (213)Bi-labeled monoclonal antibody MX35 in an ovarian cancer model

BACKGROUND: The aim of this study was to compare the therapeutic efficacy of two different activity levels of the (213)Bi-labeled monoclonal antibody MX35 in an ovarian cancer model. Sixty female BALB/c (nu/nu) mice were inoculated intraperitoneally with human ovarian cancer cells (OVCAR-3). Two wee...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:EJNMMI Res
Autors principals: Gustafsson-Lutz, Anna, Bäck, Tom, Aneheim, Emma, Hultborn, Ragnar, Palm, Stig, Jacobsson, Lars, Morgenstern, Alfred, Bruchertseifer, Frank, Albertsson, Per, Lindegren, Sture
Format: Artigo
Idioma:Inglês
Publicat: Springer Berlin Heidelberg 2017
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5403775/
https://ncbi.nlm.nih.gov/pubmed/28439844
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13550-017-0283-2
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars